Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at Diagnosis Compared to At-Risk Group According to European Leukemia Net 2017 Risk Stratification.
作者:
DOI
10.3390/cancers14133199
PMID
35804971
发布时间
2023-03-08
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文